Study of Oral Debio 0123 in Combination With Carboplatin in Participants With Advanced Solid Tumors

NCT03968653 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

76

Enrollment

INDUSTRY

Sponsor class

Stopped This trial was concluded for strategic reasons.

Conditions

Advanced Solid Tumors

Interventions

DRUG: Debio 0123
DRUG: Carboplatin
DRUG: Debio 0123
DRUG: Carboplatin

Sponsor

Debiopharm International SA